企業プロフィール
Johnson & Johnson 株価・ニュース・カタリスト
- ティッカー:
- JNJ
- 取引所:
- NYSE
- セクター:
- Biopharma, Small Molecule Drugs, Nucleic Acid Drugs, Novel Therapies
- 所在地:
- United States
株価パフォーマンス
273.04 USD (+1.04%)
終値
最終更新: 2026年8月24日
537B USD
時価総額
株価変動の要因
As of Aug 24, 2026, JNJ closed up 1.04% at $273.04. No new same-company headline was identified in the current news window.
企業概要
事業概要
Johnson & Johnson is a global healthcare leader spanning innovative medicines and medtech. Its scale, diversification, and broad therapeutic reach make it one of the most important names in the sector.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, J&J has a global footprint across pharmaceuticals and medical devices. It is a diversified healthcare company rather than a pure biotech or single-segment platform.
ビジネスモデルの特徴
The company generates value through product sales across medicines, surgery, orthopedics, and medtech franchises. Investors focus on pipeline depth, launch execution, and the ability to replace mature products with new growth drivers.
バイオ業界での位置付け
J&J sits above the biotech cycle as a diversified healthcare bellwether. It is less volatile than development-stage biotech, but regulatory and pipeline updates still matter because they shape long-term growth expectations.
今後のカタリスト
- Johnson & Johnson’s near-term watchpoints are the TAR-210 uro-oncology program, RYBREVANT FASPRO rollout, and any further updates that show whether the company can keep turning new assets into commercial momentum. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。